RxDoctor Payments Data

Karla Lorincy

Family · Phoenix, AZNPI 1871204685

Payments from drug & device makers

$6,853in general payments, 2019–2025

Across 407 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Eisai Inc.$680
  • Pfizer$388
  • Lilly USA, LLC$371
  • Novartis$288
  • AstraZeneca$262
  • plus $2K from 31 others

What the payments were for

  • Food & beverage$6,853100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,853 in reported general payments places this provider in the 95th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate13$21,117
QuliptaAtogepant19$19,685
Gabapentin176$3,673
Memantine Hcl56$3,151
Donepezil Hcl112$2,541
Eletriptan HbrEletriptan Hydrobromide16$2,140
Sumatriptan Succinate23$2,042
Tizanidine Hcl24$1,080
Duloxetine Hcl32$1,039
Pregabalin53$888
Propranolol Hcl ErPropranolol Hcl26$619
Levetiracetam28$571
Primidone26$487
Baclofen14$446
Ropinirole Hcl17$442

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$388$21,11713 claims
AbbVieQulipta$2,502$19,68519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,119 family providers in Arizona.

Other family in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →